Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 x 10(-9)). This was replicated in a Danish cohort (P = 4.8 x 10(-3)) and in a US cohort (P = 3.3 x 10(-9)). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box-containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of associated loci are linked to beta cells, supporting the idea that impaired beta cell function is critical to type 2 diabetes pathogenesis78,80.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“The first associated loci, in genes including TCF7L2, INSR, IRS1, GCK and KCNJ11 (refs.77,78), were originally identified by linkage or candidate gene studies, and since the turn of the century, increasing size and depth of genome-wide association studies have rapidly expanded the list of associated loci in type 2 diabetes to more than 250 with 400 independent signals79.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“unequivocal replications are so far limited to variants in just three genes: PPARG, KCNJ11 and TCF7L2 (2-4).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [4]
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“The prevalence of type 2 diabetes worldwide is 6% but is projected to rise over the next decade owing to increasing age of the population and surge of obesit”
BackgroundConvergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,515 · cited 1×
“The β-catenin protein is also important for mediating cell adhesion through its binding of cadherin”
BackgroundThe common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P. J., & Clevers, H. (1998) · Nature Genetics · doi:10.1038/1270 · Cited by 1,581
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 1×
“Similar to TCF7L2 , five of the six positionally cloned genes for the rare mendelian forms of type 2 diabetes, maturity-onset diabetes of the young (MODY), are transcription factor”
BackgroundAllele-Sharing Models: LOD Scores and Accurate Linkage Tests
Kong, A., & Cox, N. J. (1997) · The American Journal of Human Genetics · doi:10.1086/301592 · Cited by 979
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Cited by
Items 701–800 of 1,004
Glucose regulation of β ‐cell stress in type 2 diabetes
Leibowitz, G., Bachar-Wikström, E., Shaked, M., Sinai, A., Ketzinel‐Gilad, M., Cerasi, E., & Kaiser, Ν. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01280.x · Cited by 51
“Genomewide linkage analysis discovered several genetic variants that are associated with increased risk of diabetes [4,5].”
BackgroundGui, S., Yuan, G., Wang, L., Zhou, L., Xue, Y., Yu, Y., Zhang, J., Zhang, M., Yang, Y., & Wang, D. W. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24490 · Cited by 47
DeMenna, J., Puppala, S., Chittoor, G., Schneider, J., Kim, J. Y., Shaibi, G. Q., Mandarino, L. J., Duggirala, R., & Coletta, D. K. (2014) · Human Heredity · doi:10.1159/000363411 · Cited by 45
Zhao, J., Schug, J., Li, M., Kaestner, K. H., & Grant, S. F. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1852-3 · Cited by 46
“It was initially speculated that TCF7L2 operated in tandem with insulin to influence blood glucose homeostasis by altering levels of glucagon-like peptide 1 [1, 7].”
BackgroundMethodSelf-citationNovel Avenues of Drug Discovery and Biomarkers for Diabetes Mellitus
Maiese, K., Chong, Z. Z., Shang, Y. C., & Hou, J. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010362904 · Cited by 46
Prokunina‐Olsson, L., Kaplan, L. M., Schadt, E. E., & Collins, F. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007231 · Cited by 46
“Common intronic single nucleotide polymorphisms (SNPs) within the transcription factor 7 - like 2 gene (TCF7L2) have been identified as genetic factors that significantly increase risk of type 2 diabetes (T2D) [1,2,3,4].”
BackgroundSilviera, M. L., Smith, B. P., Powell, J., & Sapienza, C. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0336 · Cited by 47
New-onset diabetes after transplantation: Risk factors and clinical impact
Räkel, A., & Karelis, A. D. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.09.003 · Cited by 52
“[36] Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, et al.”
BackgroundBodhini, D., Gaal, S., Shatwan, I. M., Ramya, K., Ellahi, B., Surendran, S., Sudha, V., Anjana, M., Mohan, V., Lovegrove, J. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188382 · Cited by 48
“Strong association between the MC4R gene and risk of obesity was identified by a genome-wide association (GWAS) study [9] whereas the association between the Transcription Factor 7-Like 2 (TCF7L2) gene and risk of T2D was identified by a genome wide linkage study [10].”
Plengvidhya, N., Chanprasert, C., Chongjaroen, N., Yenchitsomanus, P., Homsanit, M., & Tangjittipokin, W. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0614-9 · Cited by 49
“A strong association was identified between TCF7L2 genetic variants and risk of T2D in a European population [8], Table 3 Association between CDKN2A/2B (rs10811661), SLC30A8 (rs13266634), and TCF7L2 (rs7903146) genotypes and quantitative traits among Thai patients with T2D”
BackgroundPapandreou, C., Li, J., Liang, L., Bulló, M., Zheng, Y., Ruiz‐Canela, M., Yu, E., Guasch‐Ferré, M., Razquín, C., Clish, C. B., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39441-6 · Cited by 53
Central signalling cross‐talk between insulin and leptin in glucose and energy homeostasis
Boucsein, A., Kamstra, K., & Tups, A. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12944 · Cited by 52
Holmkvist, J., Tojjar, D., Almgren, P.-E., Lyssenko, V., Lindgren, C. M., Isomaa, B., Tuomilehto, J., Berglund, G., Renström, E., & Groop, P. (2007) · Diabetologia · doi:10.1007/s00125-007-0846-2 · Cited by 56
“To date, genetic variants in TCF7L2, KCNJ11, TCF14 (also known as HNF-4α), TCF1 and the newly discovered genes HHEX, CDKAL1, CDKN1A/B and IGF2BP2 have been shown to influence insulin secretion and risk of type 2 diabetes [2–11].”
BackgroundGenetic and Molecular Aspects of Sport Performance
Bouchard, C., & Hoffman, E. P. (2010) · Wiley eBooks · doi:10.1002/9781444327335 · Cited by 63
Ereqat, S., Nasereddin, A., Cauchi, S., Azmi, K., Abdeen, Z., & Amin, R. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0161-0 · Cited by 45
Alami, F. M., Ahmadi, M., Bazrafshan, H., Tabarraei, A., Khosravi, A., Tabatabaiefar, M. A., & Samaei, N. M. (2012) · Genetics and Molecular Biology · doi:10.1590/s1415-47572012005000029 · Cited by 45
“Accounting for 90~95% of populations with diabetes, T2DM is predicted to reach 300 million people worldwide by the year 2025 (Zimmet et al., 2001; Grant et al., 2006;).”
BackgroundGenotype Prediction of Adult Type 2 Diabetes From Adolescence in a Multiracial Population
Vassy, J. L., DasMahapatra, P., Meigs, J. B., Schork, N. J., Magnussen, C. G., Chen, W., Raitakari, O. T., Pencina, M. J., Jamal, S. M., Berenson, G. S., et al. (2012) · Pediatrics · doi:10.1542/peds.2012-1132 · Cited by 46
Mouse models and the interpretation of human GWAS in type 2 diabetes and obesity
Cox, R., & CHURCH, C. D. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.000414 · Cited by 53
“replicated in two other populations of European ancestry (Grant et al., 2006).”
BackgroundResultInfluentialZhou, B., Wei, F., Kanai, N., Fujimura, A., Kaitsuka, T., & Tomizawa, K. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu184 · Cited by 51
The TCF7L2rs7903146 polymorphism, dietary intakes and type 2 diabetes risk in an Algerian population
Ouhaïbi-Djellouli, H., Médiène-Benchekor, S., Lardjam-Hetraf, S. A., Hamani-Medjaoui, I., Meroufel, D. N., Boulenouar, H., Hermant, X., Saïdi‐Mehtar, N., Amouyel, P., Houti, L., et al. (2014) · BMC Genetics · doi:10.1186/s12863-014-0134-3 · Cited by 49
“An association between rs7903146 of the transcription factor 7like 2 (TCF7L2) gene and the T2D risk was identified for the first time in a study of Icelandic, American and Danish subjects [4], and has since been consistently replicated in various European and non-European populations (including Indian and Japanese pop…”
ResultMetabolic syndrome: is equine disease comparable to what we know in humans?
Ertelt, A., Barton, A. K., Schmitz, R. R., & Gehlen, H. (2014) · Endocrine Connections · doi:10.1530/ec-14-0038 · Cited by 55
A Recessive Gene for Primary Vesicoureteral Reflux Maps to Chromosome 12p11-q13
Weng, P. L., Sanna‐Cherchi, S., Hensle, T. W., Shapiro, E., Werzberger, A., Caridi, G., Izzi, C., Konka, A., Reese, A. C., Cheng, R., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111199 · Cited by 45
Cellular Senescence, Neurological Function, and Redox State
Maciel-Barón, L. Á., Moreno-Blas, D., Morales-Rosales, S. L., González-Puertos, V. Y., López-Díazguerrero, N. E., Torres, C., Castro-Obregón, S., & Königsberg, M. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7112 · Cited by 45
“Increased risk for type 2 diabetes has been linked with specific WNT component modifications (65).”
Regulation of body weight and energy homeostasis by neuronal cell adhesion molecule 1
Rathjen, T., Yan, X., Kononenko, N. L., Ku, M., Song, K., Ferrarese, L., Tarallo, V., Puchkov, D., Kochlamazashvili, G., Brachs, S., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4590 · Cited by 52
Rees, S. D., Bellary, S., Britten, A., OʼHARE, J. P., Kumar, S., Barnett, A. H., & Kelly, M. A. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-8 · Cited by 45
“[1] in Icelandic subjects and associations with surrogate markers were subsequently confirmed in several other populations Published: 21 February 2008”
An islet in distress: β cell failure in type 2 diabetes
Ogihara, T., & Mirmira, R. G. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00021.x · Cited by 50
Alibegovic, A. C., Sonne, M. P., Højbjerre, L., Hansen, T., Pedersen, O., van Hall, G., Holst, J. J., Stallknecht, B., Dela, F., & Vaag, A. (2010) · Diabetes · doi:10.2337/db09-0918 · Cited by 45
Pathogen evolution in a vaccinated world
Read, A. F., & Mackinnon, M. J. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0011 · Cited by 51
Genetics of Type 2 Diabetes and Clinical Utility
Dorajoo, R., Liu, J., & Boehm, B. O. (2015) · Genes · doi:10.3390/genes6020372 · Cited by 53
“Although much effort was invested in these studies the only major success was the identification of the transcription factor 7-like 2 gene (TCF7L2) and most of the other putative candidates remain to be validated [18].”
BackgroundMarquezine, G. F., Pereira, A., Sousa, A., Mill, J., Hueb, W. A., & Krieger, J. E. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-106 · Cited by 44
Blackett, P. R., & Sanghera, D. K. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.04.079 · Cited by 51
“In studies in which overt type 2 diabetes has been the phenotype, the majority of associated polymorphisms have encoded proteins known to be involved in b-cell metabolism; for example, TCF7L2, KCNJ11, and HHEX have shown robust association.(152,153) The HHEX gene was shown to be associated with increased risk for type…”
BackgroundBasile, K. J., Guy, V. C., Schwartz, S. S., & Grant, S. F. A. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0550-9 · Cited by 49
“It is well established that common genetic variation within the human leukocyte antigen (HLA) class II loci explains a sizable proportion of the genetic risk for T1D in the young, while the strongest associated T2D variant is found within intron 3 of the gene-encoding transcription factor 7-like 2 (TCF7L2) [42].”
BackgroundSelf-citationTCF7L2 Variation and Proliferative Diabetic Retinopathy
Luo, J., Zhao, L., Chen, A. Y., Zhang, X., Zhu, J., Zhao, J. J., Ouyang, H., Luo, H., Song, Y., Lee, J. S., et al. (2013) · Diabetes · doi:10.2337/db12-1093 · Cited by 46
“Common variant rs7903146 in TCF7L2 has been reported to be strongly associated with type 2 diabetes mellitus (T2DM), and this finding has been replicated in many studies (8,9).”
BackgroundCheng, P., Chen, Y.-Y., Cheng, W., Lu, P., Chen, H., Chen, B.-R., Yeh, T., Sun, G., Hsiao, M., & Tseng, C.-J. (2015) · Diabetes · doi:10.2337/db14-1439 · Cited by 46
“It is via the Wnt signaling pathway that TCF7L2 regulates the proglucagon gene expression in enteroendocrine cells (20).”
BackgroundSulwon Lecture 2009: The Search for Genetic Risk Factors of Type 2 Diabetes Mellitus
Park, K. S. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.1.12 · Cited by 56
“The most significant finding derived from the candidate gene approach is the strong association of TCF7L2 gene [13].”
BackgroundHindy, G., Mollet, I. G., Rukh, G., Ericson, U., & Orho‐Melander, M. (2016) · Genes & Nutrition · doi:10.1186/s12263-016-0524-4 · Cited by 46
“Of these, the transcription factor 7like 2 gene (TCF7L2) variant rs7903146 shows the strongest association with type 2 diabetes [12].”
BackgroundKronenberg, F. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.09.005 · Cited by 45
Prevalence of common disease-associated variants in Asian Indians
Pemberton, T. J., Mehta, N. U., Witonsky, D., Rienzo, A. D., Allayee, H., Conti, D. V., & Patel, P. I. (2008) · BMC Genetics · doi:10.1186/1471-2156-9-13 · Cited by 52
“98386G>T IVS4 rs12255372 Type-2 diabetes [103]”
Support for involvement of the AHI1 locus in schizophrenia
Ingason, A., Sigmundsson, T., Steinberg, S., Sigurðsson, E., Haraldsson, M. H., Magnúsdóttir, B. B., Frigge, M. L., Kong, A., Gulcher, J. R., Þorsteinsdóttir, U., et al. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201848 · Cited by 50
Self-citationTranslating TCF7L2: from gene to function
Pearson, E. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1356-1 · Cited by 46
“Prior to 2006, only two genes were established type 2 diabetes loci (PPARG [ 1 ]a ndKCNJ11 [2]).”
BackgroundAl‐Daghri, N. M., Alkharfy, K. M., Alokail, M. S., Alenad, A. M. H., Al-Attas, O. S., Mohammed, A. K., Sabico, S., & Albagha, O. (2013) · Clinical Endocrinology · doi:10.1111/cen.12187 · Cited by 56
Association of gene variants with susceptibility to type 2 diabetes among Omanis
Al-Sinani, S., Woodhouse, N., Al-Mamari, A., Al-Shafie, O., Al-Shafaee, M., Al-Yahyaee, S., Hassan, M., Jaju, D., Al-Hashmi, K., Al-Abri, M., et al. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.358 · Cited by 47
Smushkin, G., Sathananthan, M., Sathananthan, A., Dalla Man, C., Micheletto, F., Zinsmeister, A. R., Cobelli, C., & Vella, A. (2012) · Diabetes · doi:10.2337/db11-1732 · Cited by 43
“This led to the suggestion that TCF7L2 predisposed to diabetes via alterations in posttranslational processing of proglucagon to GLP-1 (7).”
BackgroundChiang, Y.-T. A., Shao, W., Xu, X. X., Chernoff, J., & Jin, T. (2012) · Endocrinology · doi:10.1210/en.2012-1781 · Cited by 48
Karamanakos, G., Kokkinos, A. D., Dalamaga, Μ., & Liatis, S. (2022) · Current Obesity Reports · doi:10.1007/s13679-022-00477-x · Cited by 49
Christofidou, P., Nelson, C. P., Nikpay, M., Qu, L., Li, M., Loley, C., Dębiec, R., Braund, P. S., Denniff, M. J., Charchar, F. J., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.06.001 · Cited by 49
Self-citationHeterogeneity in gene loci associated with type 2 diabetes on human chromosome 20q13.1
Bento, J. L., Palmer, N. D., Zhong, M., Roh, B. H., Lewis, J. P., Wing, M. R., Pandya, H., Freedman, B. I., Langefeld, C. D., Rich, S. S., et al. (2008) · Genomics · doi:10.1016/j.ygeno.2008.06.004 · Cited by 50
“5, comparable to effect size for the recently discovered T2DM susceptibility gene TCF7L2, transcription factor 7-like 2 [40], or very frequent variants (N10k).”
BackgroundThe ecology and evolution of antibiotic-resistant bacteria
Bergstrom, C. T., & Feldgarden, M. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0010 · Cited by 50
Wang, X., Lei, X. G., & Wang, J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.09.003 · Cited by 46
Transcriptomics in type 2 diabetes: Bridging the gap between genotype and phenotype
Jenkinson, C. P., Göring, H. H. H., Arya, R., Blangero, J., Duggirala, R., & DeFronzo, R. A. (2015) · Genomics Data · doi:10.1016/j.gdata.2015.12.001 · Cited by 51
“However, common variants identified by GWAS explain only about 10% of the total trait variance for T2D [29] and less than 5% of the trait variance for obesity [4], indicating that a large proportion of trait variance, and of heritability, is still unexplained [48].”
BackgroundSalinas, Y. D., Wang, L., & DeWan, A. T. (2016) · BMC Genetics · doi:10.1186/s12863-016-0387-0 · Cited by 44
“We propose two possible explanations for this: that our study was insufficiently powered to detect the purported effect size for rs7903146 in Europeans (−0.02 kg/m2 per (minor) allele [8]), and/or that, unlike our study, which consisted entirely of population-based samples, the Locke et al. meta-analysis also included…”
Influentialβ-Catenin Directs Long-Chain Fatty Acid Catabolism in the Osteoblasts of Male Mice
Frey, J. L., Kim, S. P., Li, Z., Wolfgang, M. J., & Riddle, R. C. (2018) · Endocrinology · doi:10.1210/en.2017-00850 · Cited by 41
“metabolic activity in the liver (40), and polymorphisms in the human gene are associated with increased risk for developing type 2 diabetes (41, 42).”
Transcription factors: Time to deliver
Ulasov, A. V., Rosenkranz, A. A., & Sobolev, A. S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.004 · Cited by 45
The role of adherens junction proteins in the regulation of insulin secretion
Dissanayake, W. C., Sorrenson, B., & Shepherd, P. R. (2018) · Bioscience Reports · doi:10.1042/bsr20170989 · Cited by 44
The Influence of Type 2 Diabetes–Associated Factors on Type 1 Diabetes
REDONDO, M. J., Evans‐Molina, C., Steck, A. K., Atkinson, M. A., & Sosenko, J. M. (2019) · Diabetes Care · doi:10.2337/dc19-0102 · Cited by 47
“TCF7L2 TCF7L2 single nucleotide polymorphisms (SNPs) are the genetic factors most strongly associated with type 2 diabetes (9).”
BackgroundSmoking-by-genotype interaction in type 2 diabetes risk and fasting glucose
Wu, P., Rybin, D. V., Bielak, L. F., Feitosa, M. F., Franceschini, N., Li, Y., Lu, Y., Marten, J., Musani, S. K., Noordam, R., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230815 · Cited by 47
Self-citationDe Silva, N. M. G., & Frayling, T. M. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328334fdb6 · Cited by 43
Sanghera, D. K., Been, L. F., Ortega, L., Wander, G. S., Mehra, N. K., Aston, C. E., Mulvihill, J. J., & Ralhan, S. K. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2009.7 · Cited by 46
Zhu, H., Zhao, Z., Liu, H., Cai, J., Lu, Q., Ji, L., & Xu, J. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2191218 · Cited by 46
“genetic evidence for the role of the transcription factor 7-like 2 (TCF7L2) gene in the relationship between T2DM and adaptive evolution [226,227]; the researchers observed potential positive selection for HapA (a cluster of homogeneous haplotypes in TCF7L2), which was linked with T2DM, as well as several phenotypic t…”
BackgroundPrecision medicine and nucleotide-based therapeutics to treat steatotic liver disease
Caddeo, A. M., & Romeo, S. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0438 · Cited by 47
Glut4 expression defines an insulin-sensitive hypothalamic neuronal population
Ren, H., Yan, S., Zhang, B., Lu, T. Y., Arancio, O., & Accili, D. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.04.006 · Cited by 37
“Similarly Tcf7l2, a diabetes susceptibility gene [18] that had been originally linked to b-cell function, is expressed at high levels in the midbrain [19]e consistent with the present data e and has been found to regulate glucagon gene expression [20].”
Erythropoietin, Forkhead Proteins, and Oxidative Injury: Biomarkers and Biology
Maiese, K., Hou, J., Chong, Z. Z., & Shang, Y. C. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.121 · Cited by 41
“Abnormalities in the Wnt pathway, such as with transcription factor 7-like 2 gene, may impart increased risk for type 2 DM in some populations[228,229,230] as well as have increased association with obesity[231].”
BackgroundLin, P., Lin, W., Yeh, Y.-H., & Wung, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153044 · Cited by 46
“Among common genetic variants associated with T2DM identified thus far, single nucleotide polymorphism rs7903146 of the transcription factor 7 like-2 (TCF7L2) gene produces the strongest susceptibility for T2DM [14,15] and this relationship is reproducibly shown in various ethnic groups [16].”
BackgroundKhan, I. A., Poornima, S., Jahan, P., Rao, P., & Hasan, Q. A. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/14471.6855 · Cited by 41
“Date of Submission: apr 14, 2015 Date of Peer Review: Jul 21, 2015 Date of Acceptance: aug 12, 2015 Date of Publishing: nov 01, 2015 Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, [8] et al.”
BackgroundInfluentialFamily history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA)
Hjort, R., Alfredsson, L. S., Andersson, T., Carlsson, P., Grill, V., Groop, L., Martinell, M., Rasouli, B. S., Storm, P., Tuomilehto, J., et al. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.05.010 · Cited by 47
“Recent studies have identified several genes related to T2D, of which variants within the TCF7L2 gene have the strongest effect [4].”
BackgroundType 2 diabetes – An unresolved disease across centuries contributing to a public health emergency
Cuschieri, S. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.11.010 · Cited by 46
The transcription factor 7-like 2 gene and increased risk of type 2 diabetes: an update
Lyssenko, V. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328304d970 · Cited by 47
Reinehr, T., Friedel, S., Mueller, T. D., Toschke, A. M., Hebebrand, J., & Hinney, A. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.146 · Cited by 41
Role of metabolic programming in the pathogenesis of β-cell failure in postnatal life
Simmons, R. A. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9045-1 · Cited by 53
“The recently described type 2 diabetes susceptibility gene Transcription Factor7-like 2 (TCF7L2) confers a riskallele frequency of approximately 30% [ 38 ].”
BackgroundSmushkin, G., & Vella, A. V. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833a558d · Cited by 43
Bakhtadze, E., Cervin, C., Lindholm, E., Borg, H., Nilsson, P. M., Arnqvist, H. J., Bolinder, J., Eriksson, J. W., Guðbjörnsdóttir, S., Nyström, L., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1161-2 · Cited by 46
“SNP rs7903146 in TCF7L2 gene, previously shown to be associated with type 2 diabetes, and a more recently described microsatellite marker, captured by SNP rs10885406, were genotyped [34, 35].”
BackgroundChu, W. S., Das, S. K., Wang, H., Chan, J. C. N., Deloukas, P., Froguel, P., Baier, L. J., Jia, W., McCarthy, M. I., Ng, M. C. Y., et al. (2007) · Diabetes · doi:10.2337/db06-1305 · Cited by 46
“8, or approximately the range observed for the well-replicated TCF7L2 diabetes gene (24).”
BackgroundSerbis, A., Giapros, V. I., Tsamis, K. I., Balomenou, F., Galli‐Τsinopoulou, A., & Siomou, E. C. (2023) · Nutrients · doi:10.3390/nu15092217 · Cited by 46
“Gene variants that have been linked to increased T2D risk and defective insulin processing and secretion include variants close to TCF7L2, HNF1A, HNF1B, SLC30A8, ADCY5, and MTNR1B genes.”
BackgroundZhuo, C., Zhang, Q., Wang, L., Ma, X., Li, R., Ping, J., Zhu, J., Tian, H., & Jiang, D. (2023) · CNS Drugs · doi:10.1007/s40263-023-01057-w · Cited by 48
“An association of a TCF7L2 variant with T2D risk was first reported in 2006 [44].”
BackgroundDissection of type 2 diabetes: a genetic perspective
Bonnefond, A., Florez, J. C., Loos, R. J. F., & Froguel, P. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00339-5 · Cited by 54
Dou, H., Ma, E., Yin, L., Jin, Y., & Wang, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059495 · Cited by 40
“Grant and colleagues [4] reported on the association of transcription factor 7like 2 (TCF7L2) polymorphism with T2DM in an Icelandic casecontrol sample.”
BackgroundGenetic Epidemiology of Type 2 Diabetes and Cardiovascular Diseases in Africa
Ayele, F. T., Adeyemo, A., & Rotimi, C. N. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.09.013 · Cited by 45
Barber, T. M., Bennett, A. J., Groves, C. J., Sovio, U., Ruokonen, A., Martikainen, H. K., Pouta, A. M., Hartikainen, A., Elliott, P., Wass, J. A. H., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0804-z · Cited by 40
“However, two single nucleotide polymorphisms (SNPs; rs7903146 and rs12255372) within TCF7L2 display the strongest effects on type 2 diabetes susceptibility in European populations [2], with rs7903146 the better marker overall [7].”
BackgroundPEDF-induced alteration of metabolism leading to insulin resistance
Carnagarin, R., Dharmarajan, A., & Dass, C. R. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.006 · Cited by 45
White, S. N., & Knowles, D. P. (2013) · Viruses · doi:10.3390/v5061466 · Cited by 48
“40 [164–168].”
Islet b cell failure in type 2 diabetes
Prentki, M., & Nolan, C. J. (2006) · Cited by 47
The &Bgr;-Cell in Type 2 Diabetes and in Obesity
Rutter, G. A., & Parton, L. E. (2008) · KARGER eBooks · doi:10.1159/000115360 · Cited by 46
Buraczyńska, M., Swatowski, A., Markowska-Gosik, D., Kuczmaszewska, A., & Książek, A. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.05.017 · Cited by 40
Pérez‐Martínez, P., Pérez-Caballero, A. I., García‐Ríos, A., Yubero‐Serrano, E. M., Camargo, A., Gómez-Luna, M. J., Marín, C., Gómez-Luna, P., Dembinska-Kiec, A., Rodríguez-Cantalejo, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043390 · Cited by 45
“Variations in TCF7L2 (particularly rs7903146) are a genetic risk factor for T2DM [13–15,33–34].”
BackgroundLessons from two prevalent amyloidoses—what amylin and Aβ have in common
Götz, J., Lim, Y.-A., & Eckert, A. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00038 · Cited by 45
Recent development in pharmacogenomics: from candidate genes to genome-wide association studies
Grant, S. F., & Hakonarson, H. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.4.371 · Cited by 40
Self-citationAssociation between health-service use and multiplex genetic testing
Reid, R. J., McBride, C. M., Alford, S. H., Price, C. S., Baxevanis, A. D., Brody, L. C., & Larson, E. B. (2012) · Genetics in Medicine · doi:10.1038/gim.2012.52 · Cited by 42
Pagán, A., Molina, M. S., Olza, J., Prieto‐Sánchez, M. T., Blanco‐Carnero, J. E., Parrilla, J. J., Gil, Á., & Larqué, E. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.06.024 · Cited by 40
Type 2 diabetes in children and adolescents
Amed, S., Daneman, D., Mahmud, F. H., & Hamilton, J. K. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.15 · Cited by 49
Goossens, G. H., Petersen, L. V., Blaak, E. E., Hul, G. B. J., Arner, P., Astrup, A. V., Froguel, P., Patel, K., Pedersen, O. B., Polak, J., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.59 · Cited by 39
Papadopoulou, A., Lynch, K. F., Shaat, N., Håkansson, R., Ivarsson, S. A., Berntorp, K., Agardh, C. D., Lernmark, Å., & on behalf of the DiPiS Study Group (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03359.x · Cited by 40
Aging induces a distinct gene expression program in mouse islets
Rankin, M. M., & Kushner, J. A. (2010) · Islets · doi:10.4161/isl.2.6.13376 · Cited by 44
Ectopic expression of Wnt10b decreases adiposity and improves glucose homeostasis in obese rats
Aslanidi, G., Kroutov, V., Philipsberg, G. A., Lamb, K. E., Campbell‐Thompson, M., Walter, G. A., Kurenov, S. N., Aguirre, J. I., Keller, P., Hankenson, K. D., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00248.2007 · Cited by 41
“In humans, mutations in Wnt10b are associated with obesity (6), and the variants of transcription factor 7-like 2 (TCF7L2, formerly TCF4) gene, another member of Wnt signaling pathway, confer risk of type 2 diabetes (10, 13, 42).”
A meta-analysis of QTL for diabetes-related traits in rodents
Schmidt, C., Gonzaludo, N., Strunk, S., Dahm, S., Schuchhardt, J., Kleinjung, F., Wuschke, S., Joost, H., & Al‐Hasani, H. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00267.2007 · Cited by 40
“Recently, a total of nine candidate genes for type 2 diabetes have been identified and replicated in humans through multiple genomewide association (GWA) studies of common variants by using high-density SNP mapping approaches: CDKAL1, CDKN2A/CDKN2B, FTO, HHEX, IGF2BP2, KCNJ11, PPARG, SLC30A8, and TCF7L2 (21, 25, 57, 5…”
BackgroundInfluentialPrioritized Subset Analysis: Improving Power in Genome-wide Association Studies
Li, C., Li, M., Lange, E. M., & Watanabe, R. M. (2007) · Human Heredity · doi:10.1159/000109730 · Cited by 41
“Simulations We carried out simulations to evaluate the performance of the PSA, its effect on the overall FDR, and the change in power when a disease gene region is not included in the prioritized subset. To give a practical evaluation of the PSA, we analyzed simulated GWAS data sets with LD patterns resembling real da…”
InfluentialThe use of genetic epidemiology to guide classification in child and adult psychopathology
Szatmari, P., White, J., & Merikangas, K. R. (2007) · International Review of Psychiatry · doi:10.1080/09540260701563619 · Cited by 38
“…successes applying the genome wide association study method to identify genes underlying complex diseases such as diabetes (Field et al., 2007a; Grant et al., 2006; Groves et al., 2006; Sladek et al., 2007), prostate cancer (Freedman et al., 2006; Amundadottir et al., 2006) and inflammatory…”
BackgroundMethodKurzawski, M., Dziewanowski, K., Łapczuk-Romańska, J., Wajda, A., & Droździk, M. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1292-8 · Cited by 38
“The TCF7L2 rs7903146 T allele was added to the multivariate analysis, as genotyping data were available from our previous study for all patients [20] and this SNP has also been associated with T2DM [21].”
MethodKaur, K., Pandey, A. K., Srivastava, S. P., Srivastava, R., & Datta, M. (2011) · Molecular BioSystems · doi:10.1039/c1mb05041a · Cited by 42
Kurashina, R., Ohyashiki, J. H., Kobayashi, C., Hamamura, R., Zhang, Y., Hirano, T., & Ohyashiki, K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.012 · Cited by 38
Li, R., Ou, J., Li, L., Yang, Y., Zhao, J., & Wu, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00379 · Cited by 43
“TCF7L2 is one of the strongest susceptibility genes for T2DM across different ethnicities (Grant et al., 2006).”
Background
Metadata
- Authors
- Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., Styrkarsdottir, U., Magnusson, K. P., Walters, G. B., Palsdottir, E., Jonsdottir, T., Gudmundsdottir, T., Gylfason, A., Saemundsdottir, J., Wilensky, R. L., Reilly, M. P., Rader, D. J., Bagger, Y., Christiansen, C., Gudnason, V., Sigurdsson, G., Thorsteinsdottir, U., Gulcher, J. R., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- National University Hospital of Iceland (IS)
- University of Pennsylvania (US)
- Center for Clinical & Basic Research (DK)
- Icelandic Heart Association (IS)
- Corresponding author
- Grant, Struan F A
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-01-15
- Volume
- 38
- Issue
- 3
- Pages
- 320-323
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1965141016
- Cited by
- 2,287
- References
- 25
- Citations by year
- 2026: 45 · 2025: 58 · 2024: 54 · 2023: 56 · 2022: 80 · 2021: 86 · 2020: 76 · 2019: 86 · 2018: 86 · 2017: 85 · 2016: 99 · 2015: 109 · 2014: 125 · 2013: 125 · 2012: 156
- FWCI
- 127.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- University of Pennsylvania
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, TCF7L2, transcription factor 7-like 2, chromosome 10q, genetic susceptibility, blood glucose homeostasis, Wnt signaling, Icelandic population, Danish population, United States population
- MeSH terms
- Chromosome Mapping, Chromosomes, Human, Pair 10, Denmark, Diabetes Mellitus, Type 2, Gene Frequency, Genetic Carrier Screening, Humans, Introns, Molecular Sequence Data, Reference Values, Cohort Studies, Microsatellite Repeats, Genetic Predisposition to Disease, TCF Transcription Factors, Transcription Factor 7-Like 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.